VM-200

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameVM-200
Drug Alias NameVM200
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAldehydes inhibitors
TargetsAldehydes
Therapy Area/IndicationsMetabolic DiseasesSjogren-Larsson SyndromeMacular Degeneration +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCase Western Reserve University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVision Medicines
Active IndicationsN/A
Inactive IndicationsMetabolic DiseasesSjogren-Larsson SyndromeMacular Degeneration +[4] 

Other Information

ATC CodeN/A
Related LinksN/A